Cargando…
Biased signaling downstream of epidermal growth factor receptor regulates proliferative versus apoptotic response to ligand
Inhibition of epidermal growth factor receptor (EGFR) signaling by small molecule kinase inhibitors and monoclonal antibodies has proven effective in the treatment of multiple cancers. In contrast, metastatic breast cancers (BC) derived from EGFR-expressing mammary tumors are inherently resistant to...
Autores principales: | Ali, Remah, Brown, Wells, Purdy, Stephen Connor, Davisson, V. Jo, Wendt, Michael K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155319/ https://www.ncbi.nlm.nih.gov/pubmed/30250119 http://dx.doi.org/10.1038/s41419-018-1034-7 |
Ejemplares similares
-
Integrin-mediated resistance to epidermal growth factor receptor-targeted therapy: an inflammatory situation
por: Brown, Wells S, et al.
Publicado: (2014) -
Radiotherapy Upregulates Programmed Death Ligand-1 through the Pathways Downstream of Epidermal Growth Factor Receptor in Glioma
por: Song, Xing, et al.
Publicado: (2018) -
In Vitro Effects of Ligand Bias on Primate Mu Opioid Receptor Downstream Signaling
por: Zhang, Xiao, et al.
Publicado: (2020) -
Fractalkine has anti-apoptotic and proliferative effects on human vascular smooth muscle cells via epidermal growth factor receptor signalling
por: White, Gemma E., et al.
Publicado: (2010) -
Potential for Modulation of the Fas Apoptotic Pathway by Epidermal Growth Factor in Sarcomas
por: Joyner, David E., et al.
Publicado: (2011)